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• As bioaccessibility in 24 housedust samples was assessed using four in vitro assays.
• As bioaccessibility was higher in housedust than contaminated soil.
• Variation of As bioaccessibility among assays was similar for housedust and soil.
• Different gastric components explained the variation in bioaccessibility assays.
• Exposure from housedust may be higher than soil due to higher bioaccessibility.
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Introduction
Human exposure to As, a group I human carcinogen (IARC, International Agency for Research on Cancer, 2004) , causes adverse health effects, including skin, bladder, lung, and kidney cancers (Celik et al., 2008; Smith et al., 1998) . Among various As exposure pathways, incidental ingestion of housedust and contaminated soil is an important non-dietary pathway for children (ATSDR, 2007) . Recent studies have shown that not all contaminants in housedust and soil can be absorbed into the systemic circulation following oral ingestion (i.e., bioavailability b100%) and As bioavailability varies with contamination sources and soil properties (Juhasz et al., 2009 ). Therefore, a reliable assessment of human health risk associated with As exposure depends on accurate measurement of site-specific As bioavailability in housedust and soil.
In vivo animal models including swine and mouse have been used to determine As relative bioavailability (relative to the absorption of soluble sodium arsenate) in soils (Juhasz et al., 2007) . However, due to cost and ethical considerations, simple in vitro assays are developed to assess As bioaccessibility in soils, i.e., the fraction of As dissolved in simulated human gastrointestinal (GI) fluids (Ruby et al., 1999) . Common methods, including the Solubility Bioaccessibility Research Consortium (SBRC), in vitro gastrointestinal (IVG), Deutsches Institut für Normung e.V. (DIN), physiologically based extraction test (PBET), and unified BARGE method (UBM), have been used to assess As bioaccessibility in contaminated soils (DIN, 2000; Kelley et al., 2002; Rodriguez et al., 1999; Ruby et al., 1996; Wragg et al., 2011) . However, their application to housedust is limited, though As contamination in housedust has received much attention recently (Hensley et al., 2007; Rasmussen et al., 2013; Rieuwerts et al., 2006; Tsuji et al., 2005; Wolz et al., 2003) .
Though in vitro methods have been widely used to measure As bioaccessibility in contaminated soils, they vary considerably in terms of solution composition, gastric and intestinal pH, extraction time, and soil/solution ratio (Table S1 ). Therefore, different methods produce different As bioaccessibility in soils. Oomen et al. (2002) compared As bioaccessibility in 3 As-contaminated soils using SBET, DIN, RIVM, SHIME, and TIM assays. Arsenic bioaccessibility varied significantly, ranging from 1.0 to 95%. Juhasz et al. (2009 Juhasz et al. ( , 2011 compared As bioaccessibility in 12 As-contaminated soils from Australia using SBRC, IVG, DIN, PBET, and UBM assays. Average As bioaccessibility based on gastric phase of UBM (33%) and SBRC (33%) are significantly higher than those using IVG (22%), DIN (15%), and PBET (20%) mainly due to differences in extraction pH (1.5 vs. 1.8, 2.5, and 2.0). Similarly, Juhasz et al. (2014) found a large variation in As bioaccessibility in 10 As-contaminated soils from USA, with gastric phase of SBRC assay providing significantly higher As bioaccessibility than those by IVG, PBET, DIN, and UBM assays.
In addition to method variability, there is variability within assays. For SBRC assay, As bioaccessibility in contaminated soils is reduced by 1.1-3.6 fold (Juhasz et al., 2009 ) and 1.1-36 fold from gastric to intestinal phase. Decreased As bioaccessibility in contaminated soils by SBRC assay corresponds with reduced soluble Fe from gastric phase to intestinal phase, suggesting adsorption of dissolved As onto newly-formed Fe oxides. However, such sharp reduction in As bioaccessibility from gastric phase to intestinal phase is not observed for IVG, DIN, and UBM assays though dissolved Fe precipitates in intestinal phase. For PBET assay, increased As bioaccessibility is observed for some soils, possibly due to enhanced Fe solubilization by organic acids present in intestinal phase (Juhasz et al., 2009 . The reasons behind the different changes in As bioaccessibility between gastric phase and intestinal phase for different assays remain unclear. In addition, compared to contaminated soils, variability in As bioaccessibility among different assays has not been investigated for housedust. It was hypothesized that similar to soils, As bioaccessibility in housedust would vary with assays.
The objective of this study was to investigate the variability in As bioaccessibility within and between in vitro assays in housedust and compare to those in contaminated soils. 24 housedust samples from China were assessed for As bioaccessibility using 4 in vitro assays (SBRC, IVG, DIN, and PBET) and were compared to As-contaminated soils. In vitro assays were modified by changing gastric components to investigate the mechanisms responsible for the variation in As bioaccessibility with assays. Furthermore, As bioaccessibility values by different assays were used to calculate daily As intake to compare As exposure between incidental ingestion of housedust and soil. Such knowledge helps to develop robust in vitro assays to assess As bioaccessibility in housedust and soils.
Materials and methods
Housedust and As-contaminated soils
Arsenic bioaccessibility in 24 housedust samples from 24 homes in 15 cities in China was determined using four in vitro assays. These dust samples were not contaminated as they were collected from regular homes in different cities with no point sources of As contamination, such as mining and smelting activities. Dried dust samples (b 150 μm) were digested using the USEPA 3050B method and analyzed for total As and Fe concentrations using inductively coupled plasma mass spectrometry (ICP-MS, NexION 300X, Perkin Elmer, USA) and flame atomic absorption spectrophotometry (FAAS, PinAAcle 900T, Perkin Elmer, USA). Total organic carbon (TOC) content was determined using an element analyzer (vario TOC select, Elementar, Germany) after removing carbonate carbon with HCl. Detailed information about sampling and processing of housedust can be found in Li et al. (2014) . Table 1 details physicochemical properties of housedust including total As and Fe concentrations and TOC. Juhasz et al. (2009) determined As bioaccessibility in 12 Ascontaminated soils (from railway corridor, dip, mine, and gossan sites) with As concentrations of 42-1114 mg kg −1 using four in vitro assays (SBRC, IVG, DIN, and PBET). Similarly, Juhasz et al. (2014) assessed the variation of As bioaccessibility in additional 10 As-contaminated soils (173-6899 mg As kg −1 ). In addition, Li et al. (2015) investigated 12
As-contaminated soils (22-4172 mg As kg
) from different contaminated sites in China. In this study, As bioaccessibility data for the 34 soils from three studies were compiled and compared to those of housedust. Table 2 details total As and Fe concentrations and TOC in the soils.
Arsenic bioaccessibility in housedust using four in vitro assays
To compare housedust and soils, the same assays (SBRC, IVG, DIN, and PBET) as those in Juhasz et al. (2014) were applied to determine As bioaccessibility in 24 housedust samples. Table S1 shows the constituents and operational parameters for each assay. Arsenic bioaccessibility in housedust (b 150 μm) was determined using gastric and intestinal solutions (DIN, 2000; Kelley et al., 2002; Rodriguez et al., 1999; Ruby et al., 1996) . Extracts were filtered (0.45 μm) and diluted with 0.1 M HNO 3 for analysis of As and Fe using ICP-MS and FAAS. Full details on extractions are given in the Supplementary data.
Arsenic bioaccessibility in housedust was calculated by dividing As concentration extracted based on the gastric or intestinal phases of assays by the total As concentration in the b150 μm fraction and expressed on a percentage basis. Arsenic bioaccessibility and extractable Fe data in soils were retrieved from Juhasz et al. (2009 Juhasz et al. ( , 2014 and Li et al. (2015) .
Modification of in vitro assays
The four assays varied in gastric components, i.e., glycine for SBRC, pepsin for IVG, pepsin, mucin, and KH 2 PO 4 for DIN, and pepsin and sodium citrate for PBET assay (Table S1 ). To understand the contribution of different gastric constituents to As bioaccessibility in gastrointestinal phase among the 4 assays, they were modified and tested using selected housedust samples (D3, 5, 10, 12, and 14) . The modifications are as follows. 1. Substitution of glycine with pepsin in SBRC assay, and pepsin with glycine in IVG assay. They were to compare their roles in controlling As dissolution in gastric phase and As adsorption to Fe oxides in intestinal phase. 2. Removal of sodium citrate from the gastric solution in PBET assay.
Previous study suggested that citrate extracts additional Fe from housedust in the gastric phase, but inhibits Fe precipitation in the intestinal phase, causing higher Pb bioaccessibility in the intestinal phase of PBET than that of other assays (Li et al., 2014) . 3. Removal of KH 2 PO 4 from the gastric solution in DIN assay. Previous studies found that phosphate enhances As solubilization from solid phase via competition with As (Brattin et al., 2013; Rodriguez et al., 2003) . 4. Assessment of As bioaccessibility in a dilute HCl solution at pH 1.5 followed by extraction using the intestinal solution of SBRC assay with or without 10 g L − 1 glycine, pepsin, or mucin to compare their As complexing ability.
Quality control and data analysis
All in vitro assays were conducted in triplicate with the relative standard deviation (RSD) b 10%. During ICP-MS measurement, spiked samples and standard solutions were measured every 20 samples. The average spike recovery (n = 40) was 104 ± 2.3%. A standard soil reference material (SRM NIST 2711a, National Institute of Standards and Technology) was included. Total As concentration in the SRM was 86 ± 0.8 mg kg One-way ANOVA was performed to test the differences in bioaccessible As and extractable Fe among the four assays and between housedust and soils using SAS software (version 9.1.3, NC, USA) based on Tukey's Post-hoc Test. All graphs were created using SigmaPlot (version 10.0, Systat Software Inc., San Jose, CA, USA).
Results and discussion
Arsenic bioaccessibility in housedust and contaminated soil
Reliable estimate of As exposure following oral ingestion of housedust and soil depends on total As concentration as well as As bioavailability. Various in vitro assays have been developed to estimate As bioavailability in contaminated soils Ruby et al., 1996) . In comparison, however, few measured As bioaccessibility in housedust.
In this study, As bioaccessibility based on gastric phase of SBRC, IVG, DIN, and PBET assay in 24 housedust samples were determined and they were averaging 73, 68, 53, and 48% (Fig. 1) . This was higher than the 10 and 19% in two miningimpacted housedust samples (76 and 464 mg kg −1 As) from England based on gastric phase of PBET assay (Rieuwerts et al., 2006) , but similar to the 34 and 52% in two housedust samples (3.6 and 8.7 mg As kg −1 ) from Canada based on gastric phase of SBRC assay (Dodd et al., 2013) As (mg kg
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a Values represent the mean and standard deviation of triplicate samples. ) based on gastric phase of PBET assay (Huang et al., 2014) . Miningimpacted housedust might contain insoluble As species such as arsenopyrite, therefore reducing its As bioaccessibility (Meunier et al., 2010) . The relatively high As bioaccessibility in housedust of this study suggested that their ingestion might pose a risk to human health.
Using the same 4 assays, As bioaccessibility in 34 contaminated soils has been assessed (Li et al., 2015; Juhasz et al., 2009 Juhasz et al., , 2014 . Compared to the soils, As bioaccessibility in the 24 housedust samples were significantly higher regardless of assays used (Fig. 1) Table 2 ). For example, As bioaccessibility based gastric phase of SBRC assay was 2-fold greater in housedust (73%) than soils (34%). Higher As bioaccessibility in housedust than soils was probably due to the difference in As contamination sources. Most of the 34 contaminated soils are from sites impacted by mining and smelting activities, with more As present as insoluble As species such as arsenopyrite or scorodite, resulting in lower As bioaccessibility (Meunier et al., 2010) . For example, in two smelting-impacted soils (#4 and 7, Table 2), N30% of the As is present as arsenopyrite .
In addition, differences in matrix properties such as Fe content, particle size, and TOC content also influence As dissolution from housedust and soils. Housedust usually contains higher TOC than soils due to enrichment of textile fibers, hairs, and skin cells (Rasmussen et al., 2008) . In this study, the TOC contents in housedust were 2.7-24% (Table 1) lower than those (10-294 g kg −1 ) in the 34 soils (Table 2 ). Since As sorption onto Fe oxides reduces As dissolution during gastrointestinal solution extraction, an inverse correlation between Fe contents and As bioaccessibility has been reported in contaminated soils (Juhasz et al., 2007) . In addition, the 2-fold higher As bioaccessibility in housedust may also be attributed to their finer particle size. For soils, the b250 μm particle fraction has been used in bioaccessibility analysis because this fraction most likely adheres to children's hands (USEPA, 2007) . However, in this study, particle size b 150 μm was used for housedust (Ruby and Lowney, 2012) . In short, difference in contamination source, higher TOC, lower Fe content, and particle size all contributed to higher As bioaccessibility in housedust. Hence more research should be devoted to study As bioaccessibility in housedust.
Variability in As bioaccessibility among the gastric phases of in vitro assays
Because in vitro assays vary considerably in gastrointestinal fluid composition, pH, and extraction times (Table S1 ), different As bioaccessibility results have been obtained for contaminated soils using different methods (Juhasz et al., 2009 . However, a similar study has not been done for housedust. Arsenic bioaccessibility in 24 housedust using the gastric phases of SBRC, IVG, DIN, and PBET assays varied greatly ( Fig. 2A) . Among the four assays, the gastric phase of SBRC assay produced the highest As bioaccessibility in housedust. This was similar to As-contaminated soils, with the gastric phase of SBRC assay producing the highest As bioaccessibility (Fig. 2B) . As gastric pH influences the dissolution of As and associated minerals such as Fe oxides from soils, higher As bioaccessibility in soils using gastric phase of SBRC than IVG, DIN, and PBET assays has been attributed to its lower pH of 1.5 versus 1.8, 2.0, and 2.5 (Juhasz et al., 2009 . In this study, higher As bioaccessibility in housedust using gastric phase of SBRC than IVG and DIN assays was companied by significantly (p b 0.05) higher extractable Fe (Fig. 3A) . The concurrent Fe and As dissolution during gastric extraction suggested that dissolution of Fe oxides also played an important role in controlling As dissolution from housedust. However, simultaneous dissolution of Fe and As in the gastric phase from housedust was not found for PBET assay. Although the PBET assay provided the lowest As bioaccessibility for housedust samples among the 4 assays ( Fig. 2A) , dissolved Fe using the PBET assay (1887 mg kg −1 ) was significantly (p b 0.05) higher than that using the IVG assay (1318 mg kg −1 ) and DIN assay (761 mg kg −1 ) assays, but similar to that using SBRC assay (2250 mg kg −1 ) (Fig. 3A) . Similar enhanced Fe dissolution from soils by the PBET assay (Fig. 3B) has been attributed to organic acids in the gastric solution of PBET assay including malate, citrate, lactic acid, and acetic acid, which complex with Fe and keep it soluble (Li et al., 2014; Nierop et al., 2002) .
In this study, removing citrate from the PBET assay significantly decreased soluble Fe concentrations from 954-3000 to 644-1656 mg kg −1 in the gastric solution of PBET assay in 5 housedust samples (Fig. 4A) , however, As bioaccessibility remained unchanged (30-69 vs. 32-74%) (Fig. 4B) . The results suggested that citrate-enhanced Fe solubilization was not accompanied by an increasing As dissolution. This was probably because As dissolved in the gastric phase of PBET assay was not associated with the Fe oxides in dusts solubilized by citrate. Although the gastric phase of PBET assay was highly effective in extracting Fe from dusts, its ability to solubilize As was the lowest among the 4 assays due to its highest gastric pH.
Variability in As bioaccessibility among the intestinal phases of in vitro assays
Compared to gastric phase, As bioaccessibility in intestinal phase was generally lower in the 24 housedust samples, but varied among assays ( Fig. 2A) . For the SBRC assay, a 1.5-12 fold decrease in As bioaccessibility in intestinal phase than gastric phase was observed for housedust (p b 0.05; Fig. 2A ). At the same time, average soluble Fe concentrations also decreased by 1.2-35 fold, from 2250 to 213 mg kg −1 (Fig. 3A) . The simultaneous decreases in bioaccessible As and soluble Fe have been reported in contaminated soils (Figs. 2B and 3B ). The higher pH in intestinal phase at 7.0 probably resulted in precipitation of dissolved Fe as amorphous Fe oxides, reducing As concentration via adsorption and/or co-precipitation (Juhasz et al., 2009 . To test this hypothesis in housedust, the gastric solution of SBRC assay from two dust samples (D10 and 14, 13.7 and 10.8 mg As kg −1 ) were filtered through a 0.45 μm filter to remove the dust matrices and extended to intestinal extraction. Analysis of the newly-formed precipitates showed that they contained 2.4 and 2.9% Fe and 138 and 59.3 mg kg −1 As. X-ray diffraction spectroscopy analyses confirmed that they were Fe oxides (data not shown). Based on As bioaccessibility of 87 and 72% in the gastric phase of SBRC assay for the two dusts,~70% of the As dissolved in gastric phase was in the precipitates, ascertaining As adsorption to Fe oxides in the intestinal solution of SBRC assay. Similar to SBRC assay, 1.1-1.9 and 8.8-186 fold decreases in As bioaccessibility and extractable Fe were observed from gastric to intestinal phase of the IVG assay ( Figs. 2A and 3A) . However, the decrease in As bioaccessibility was lower than that observed for SBRC assay (1.5-12 fold). A lower decrease in As bioaccessibility by IVG than SBRC assay has been reported for contaminated soils (Fig. 2B) . These results suggested that though Fe was precipitated in the intestinal solution of IVG assay, some components of IVG assay may have competed with Fe oxides for As sorption. The different gastric components (glycine for SBRC and pepsin for IVG assay) may have accounted for the difference. To test this hypothesis, the glycine in the SBRC assay was replaced with pepsin for extraction using 5 dust samples. Based on the modified method, As bioaccessibility increased from 6.8-28% to 19-45% in the intestinal phase (Fig. 5A) . Similarly, replacing pepsin in the IVG assay with glycine significantly decreased As bioaccessibility in intestinal phase from 35-63% to 27-44% in 5 dusts (Fig. 5B) . These results suggested that pepsin had higher As binding capacity than glycine, inhibiting As adsorption to Fe oxides in intestinal phase solutions, resulting in higher As bioaccessibility in intestinal phase for the IVG than that of SBRC assay. However, no information was available in the literature regarding the stability constant of As complexation with pepsin or glycine. Similar to SBRC and IVG assays, dissolved Fe from 24 housedust samples precipitated in the intestinal solution of DIN assay, corresponding to a significant decrease in soluble Fe from 761 to 45 mg kg − 1 (Fig. 3A) . However, a decrease in As bioaccessibility was not observed, instead As bioaccessibility in some samples increased by 15-39% ( Fig. 2A) . Similar As and Fe trends have been reported for contaminated soils (Figs. 2B and 3B) . Comparison of gastric components among assays shows that the DIN assay has a unique constituent, i.e., mucin (Table S1 ), which might be responsible for constant As bioaccessibility in gastric and intestinal phases of the DIN assay. To test this hypothesis, 5 housedust samples were extracted using diluted HCl at pH 1.5 for 1 h, then 10 g L −1 of glycine, pepsin, or mucin was added to dust suspension, and extracted using intestinal solution. The addition of glycine, pepsin, or mucin increased As bioaccessibility in the intestinal phase from 9.8-41% in the HCl control to 11-45%, 12-54%, and 45-79% (Fig. 6A) . For all 5 dust samples, the highest As bioaccessibility was obtained with mucin, followed by pepsin and glycine. The data suggested that mucin had the highest As complexation capacity to compete with Fe oxides for As sorption, keeping As soluble in the intestinal solution of DIN assay. It was also possible that mucin was adsorbed onto Fe oxides in intestinal phase, reducing As sorption onto Fe oxides during DIN assay. Future study is needed to characterize the binding ability of glycine, pepsin, and mucin to As. In addition to mucin, P is also used in gastric phase of DIN (Table S1) , which has been shown to enhance As dissolution from As-contaminated soils (Brattin et al., 2013) . This is because P and As are chemical analogs and they compete for sorption sites in soils (Rodriguez et al., 2003) . We found that removing P from DIN assay slightly decreased As bioaccessibility in housedust samples from 32-58% to 28-55% in gastric phase (Fig. 6B) . In intestinal phase, the reduction was more significant from 26-48% to 16-36%. These results suggested that P enhanced As dissolution from housedust, especially in intestinal phase of DIN assay, contributing to its higher As bioaccessibility. Different from other assays, dissolved Fe from 24 housedust samples did not precipitate in the intestinal solution of PBET assay (1887 vs. 1727 mg kg −1 ) (Fig. 3A) , resulting in higher As bioaccessibility than that of the SBRC assay (Fig. 2A) . The higher As bioaccessibility and soluble Fe in the intestinal phase of PBET assay have been reported for contaminated soils (Figs. 2B and 3B) . The higher soluble Fe probably resulted from citrate, which inhibited Fe precipitation in the intestinal phase (Li et al., 2014) . After removal of citrate from PBET assay, soluble Fe in the intestinal solution of PBET assay for 5 housedust samples sharply decreased from 953-2774 mg kg −1 to 80-768 mg kg −1 (Fig. 4A) . Accordingly, As bioaccessibility was reduced to 16-34% from 28-55% (Fig. 4B) , implying As adsorption onto Fe oxides. These results suggested that citrate sustained higher As bioaccessibility in the intestinal phase of PBET assay by inhibiting Fe from precipitation.
Daily As intake via oral ingestion of housedust and soil
After determination of As bioaccessibility using different assays, the data were incorporated into As exposure assessment following ingestion of housedust and soils. Assuming ingestion rates of housedust and soil at 60 and 50 mg per day for a child with body weight (bw) of 18.6 kg (USEPA, 2008), daily As intake values were calculated for ingestion of housedust and soil. Table 3 shows the As intake values for selected housedust and soil samples with their As bioaccessibility data shown in Table 4 .
Based on total As concentration, soil ingestion would result in daily As exposure levels of 0.20-18.6 μg kg −1 bw, with soils having As concentration N 1100 mg kg −1 exceeding the benchmark dose for 0.5% increased incidence of lung cancer (BMD0.5) at 3 μg kg −1 bw (WHO, 2011) . Compared to soils, ingestion of housedust represented significantly lower As exposure levels of 0.04-0.12 μg kg −1 bw due to low total As concentrations. However, after taking As bioaccessibility into calculation, As exposure from soil ingestion was sharply reduced to 0.02-3.75 μg kg −1 bw due to the low As bioaccessibility of 2.3-80% based on the gastric phase of SBRC assay (Table 4 ). In contrast, As intake from housedust ingestion decreased less (0.04-0.07 μg kg −1 bw) due to Table 3 Calculation of daily intake (DI) of As based on total As and bioaccessible As for selected soil and housedust samples. high As bioaccessibility of 44-96%. Therefore, the differences in As risks between ingestion of housedust and soil narrowed substantially after considering As bioaccessibility. For example, though total As concentrations in soils 10, 34, 6, and S6 (257, 577, 173 and 743 mg kg ), ingestion of soil (0.04-0.07 μg kg −1 bw) had lower or similar daily As intake compared to housedust (0.07 μg kg −1 bw) based on the gastric phase of SBRC assay. The much higher As bioaccessibility in housedust than in soil suggested the potential of a higher risk from housedust though dusts contained much less As than soils. Please note, the housedust samples collected for this study were not contaminated as they were collected from regular houses in typical cities in China. For As-contaminated housedust samples, they would pose greater risk to human health. Though As bioaccessibility can be used to refine As exposure assessment, there were significant variations in calculated As intake values between different assays since As bioaccessibility varied considerably with assays. In general, the gastric phase of SBRC assay provided a more conservative assessment of As exposure than the intestinal phase of SBRC and other assays (Table 3) . Based on the gastric phase of SBRC assay, As intake values were 0.02-3.75 and 0.04-0.07 μg kg −1 bw for soil and housedust, significantly higher than those based on other assays (0.01-1.48 and 0.01-0.07 μg kg −1 bw). The variability in
As intake values with assays can be up to 20-fold based on the gastric and intestinal phases of SBRC assay (soil 7). The large variation suggested the need for validation of in vitro assays before they are suitable for risk assessment of As exposure to human health.
Conclusions
By comparing As bioaccessibility between housedust and soil based on 4 different assays, we found that As bioaccessibility was significantly higher in housedust than that in contaminated soils, though housedust contained lower total As concentrations. This may lead to higher levels of As exposure from ingestion of housedust than soils. Similar to the variation in soils, As bioaccessibility in housedust varied considerably within and between assays. By modifying assays, the roles of different gastric components such as glycine, pepsin, mucin, phosphate, and citrate in different assays were elucidated. Our data showed that when using bioaccessibility data for As risk assessment, it is important to consider the different environmental media, which might differ significantly in As bioaccessibility. 
